Eli Lilly and Co
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
A pharmacist holds boxs of Eli Lilly & Co. Mounjaro brand tirzepatide medication arranged at a pharmacy in Provo, Utah, US, on Monday, Nov. 27, 2023. George Frey | Bloomberg | Getty Images Skyrocketing demand for a class of weight loss and diabetes treatments has lifted Eli Lilly to new heights over the last year. […]
Read More
Shares generating the biggest moves premarket: Eli Lilly, Normal Motors, Shopify
Look at out the businesses earning headlines before the bell. Eli Lilly — Eli Lilly shares rose 2% right after a panel of Food and drug administration advisors advisable the acceptance of its Alzheimer’s drug acknowledged as donanemab. Standard Motors — The automaker’s inventory added a lot more than 1% immediately after its board approved […]
Read More
FDA advisors recommend Eli Lilly’s Alzheimer’s drug donanemab, paving way for approval
Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in early US trading after its experimental drug for Alzheimer’s slowed the progress of the disease in a final-stage trial, paving the way for the company to apply for US approval. AJ Mast | Bloomberg | Getty […]
Read More
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
Attendees walk through the lobby at the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! I’m back in New York City after spending the last weekend in […]
Read More
Alphabet’s new CFO was in the middle of the GLP-1 growth. Now she’s onto generative AI
Alphabet incoming CFO Anat Ashkenazi, who invested 23 many years at Eli Lilly Eli Lilly Alphabet’s outgoing finance chief, Ruth Porat, spent the past calendar year and a fifty percent trying to assist her online firm navigate the generative synthetic intelligence increase. The human being who was just named her successor was knee-deep in a […]
Read More
Alphabet taps Eli Lilly’s Anat Ashkenazi as new CFO
A check out of Google Headquarters in Mountain Check out, California, United States on April 16, 2024. Tayfun Coskun | Anadolu | Getty Images Eli Lilly CFO Anat Ashkenazi will grow to be Alphabet’s new chief fiscal officer productive July 31, Google’s mother or father organization declared Tuesday, just about a calendar year just after […]
Read More
Why half of all workers may struggle to get weight-loss drug health insurance coverage
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Companies are increasing access to new blockbuster weight-loss drugs for employees, but size of employer may make a big difference in early access. Small businesses and their workers are often stuck […]
Read More
Wells Fargo CEO talks up reasons to love the stock — plus, what’s behind the market drop
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Market pressure : The major stock benchmarks were moving lower Wednesday, with the Dow getting the worst of it again. Adding pressure on equities, bond yields […]
Read More
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
GLP-1 Supply Tracker from Ro. Courtesy: Ro Telehealth company Ro on Wednesday launched a new tracker to help patients find a popular class of weight loss and diabetes drugs called GLP-1s amid shortages of those treatments in the U.S. The supply tracker could be a valuable tool for many Americans scrambling to get their hands […]
Read More
Buyers have designed these 9 AI plays their main holdings, Financial institution of America facts reveals
Fund managers’ really like for synthetic intelligence-linked stocks has grown as lots of of these tech businesses have turn out to be their vital holdings in the portfolio, according to Lender of America’s investigation. The Wall Avenue firm seemed at the holdings of U.S. big-cap equity mutual funds that are actively managed. It screened the […]
Read More